Abstract:Abstract INTRODUCTION: Esophageal Adenocarcinoma (EAC) represents a pressing public health concern with a rising incidence and a staggering 5-year survival rate of less than 20%, emphasizing the critical need for early detection. Barrett's Esophagus (BE) serves as a well-established precursor to EAC, presenting an opportunity for proactive screening. The salivary microbiome provides a novel opportunity to identify a high-risk population with early-stage esophageal diseases. Here, we assessed whether the oral microbiome, in combination with lifestyle and clinical data, is associated with esophageal disease progression. METHODS: The study included n=23 esophageal adenocarcinoma patients, n=51 with Barrett's Esophagus, and n=32 healthy controls. Saliva samples were collected along with comprehensive lifestyle, dietary intake, and clinical data. Shotgun Metagenomics Sequencing was employed to investigate the microbiome composition of participants. Comprehensive microbiome analyses were performed to evaluate taxonomic profiles, including microbial abundance, microbiome diversity, and functional/metabolic insights. A multi-modal data integration strategy was used to incorporate data from the Diet Health Questionnaire (DHQ) and lifestyle and health records, aiming to utilize these multimodal features to predict esophageal disease formation and progression. RESULTS: A significant difference was observed in the salivary microbiome beta diversity between healthy controls and esophagus disease groups (p= 0.03). Clustering by microbiome taxonomic composition using the Dirichlet Multinomial Mixtures (DMM) framework indicates that some microbial signatures are associated with esophageal diseases (p=0.03). Healthy Eating Index Scores, total score (p=0.01); vegetables (p=0.003); greens, and beans score (p=0.009) were significantly different between study groups. Microbial pathways associated with diet, microbial taxa linked to lifestyle and medications, and supervised classification results reveal group characteristics and diversity variations based on key covariates such as B12 and sugar uptakes. CONCLUSION: The study presents an innovative analytic approach to identify high-risk populations for esophageal diseases by integrating microbiome analysis and multi-modal data, providing insights into early detection and prevention. The potential of this research lies in its ability to revolutionize screening strategies, offering a non-invasive and cost-effective means to identify individuals at risk of EAC at earlier, more treatable stages. Citation Format: Duygu Altinok Dindar, Madeline Krieger, Amy Palma, John Cheney, Fouad Otaki, Jessica Yu, Stephanie Wood, Thomas J. Sharpton, James McGann, Lisa Karstens, Gurkan G. Yardimci, Zhenzhen Zhang. Integrating microbiome analysis and multi-modal data to identify high-risk population for esophageal adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 757.

Non-endoscopic screening for Barrett's esophagus and Esophageal Adenocarcinoma in at risk Veterans

Use of the EsoGuard® Molecular Biomarker Test in Non-Endoscopic Detection of Barrett's Esophagus among High-Risk Individuals in a Screening Population

Multicenter, Prospective Trial Of Non-Endoscopic Biomarker-Driven Detection Of Barrett'S Esophagus And Esophageal Adenocarcinoma

Enhancing the Positive Predictive Value of EGD for Diagnosis of Barrett's Esophagus Through EsoGuard® Triage

Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma

Analytical Validation of a DNA Methylation Biomarker Test for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma from Samples Collected Using EsoCheck®, a Non-Endoscopic Esophageal Cell Collection Device

Algorithm Training and Testing for a Non-Endoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts

Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma

Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis

The public's intended uptake of hypothetical esophageal adenocarcinoma screening scenarios: a nationwide survey

Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in Patients with Barrett’s Esophagus: a Western Center Experience

Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening

Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment

S581 A Community-Based Study to Assess a Prognostic Assay's Impact on Gastroenterologists' Barrett's Esophagus Patient Surveillance and Treatment Recommendations

Abstract 757: Integrating microbiome analysis and multi-modal data to identify high-risk population for esophageal adenocarcinoma

Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video)

Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With Symptomatic Gastroesophageal Reflux Increases Detection of Barrett's Esophagus and Dysplasia

Electronic clinical decision support tool for assessing stomach symptoms in primary care (ECASS): a feasibility study

Screening for Barrett’s Esophagus in the Primary Care Setting Using Tethered Capsule Endomicroscopy

Poor adherence to proper Barrett's esophagus screening and surveillance guidelines in patients with newly diagnosed esophageal adenocarcinoma